biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Response to TheTruth1234 - Lots of Fun Ahead

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Apr 16, 2023 9:25pm

86 Views

Post# 35397723

RE:RE:RE:RE:RE:RE:Response to TheTruth1234 - Lots of Fun Ahead

Trolls? We didn't need to back anything up.
The lack of anything coming to fruition was enough for us "Trolls" to know Bioasis is a nothing burger.

LoL. I feel horrible for Jane.

I can only imagine what she goes through.

<< Previous

Bullboard Posts

Next >>

Dynamic Funds Launches new ETF series on the TSX